|
NRIX Nurix Therapeutics Inc 1549595 |
| Balance Sheet |
|
Current Assets
|
$554,394,000.00 |
|
Assets
|
$636,130,000.00 |
|
Current Liabilities
|
$92,199,000.00 |
|
Liabilities
|
$155,237,000.00 |
|
Equity
|
$480,893,000.00 |
|
Shares Out
|
103399813.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-71,914,000.00 |
|
Investing Cash Flow
|
$-123,826,000.00 |
| Market Analysis |
Market Cap
|
$2,438,167,590.54 |
|
Price
|
$22.87 |
|
BVPS
|
4.65 |
|
PB
|
5.07 |
|
EPS
|
-0.79 |
|
PS
|
99.11 |
|
FCF
|
$-72,959,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Jan |
Feb |
Mar |
|
|
2026-01-28 |
-0.82 |
|
|
|
| Apr |
May |
Jun |
|
|
2026-04-08 |
-0.79 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-09 |
-0.52 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-09 |
-1.03 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NRIX documents filed with the SEC.
NRIX Filings
Clear
